Cardiology

Prehospital antiplatelets improve graft intervention outcomes

(HealthDay)—Prehospital use of antiplatelet therapy, either aspirin/clopidogrel or dual antiplatelet therapy (DAPT), is associated with a lower incidence of major adverse cardiac events after saphenous vein graft (SVG) ...

Cardiology

In CAD with GI bleeding, higher mortality with triple therapy

(HealthDay)—For patients with lower gastrointestinal bleeding (LGIB) and coronary artery disease (CAD), triple therapy is associated with increased risk of mortality at 90 days after adjustment for confounding variables, ...

Diseases, Conditions, Syndromes

Continued aspirin treatment safe with partial nephrectomy

(HealthDay)—Continuing aspirin for chronic antiplatelet therapy is safe in patients undergoing laparoscopic partial nephrectomy, according to a study published in the April issue of The Journal of Urology.

Cardiology

Dipyrone negates aspirin's antiplatelet effect

(HealthDay)—There is an unfavorable pharmacological drug interaction between the non-narcotic analgesic dipyrone and aspirin in patients with coronary artery disease (CAD), according to research published online Aug. 14 ...

Diseases, Conditions, Syndromes

Trial finds aspirin does not speed leg ulcer healing

Suggestions that aspirin may help treat venous leg ulcers have been rebutted by University of Auckland research, leaving the sufferers with compression therapy, a treatment known since the 17th Century.

Cardiology

Rivaroxaban reduces VTE recurrence compared with aspirin

In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning medication rivaroxaban reduced recurrences more than three-fold compared with aspirin, with ...

page 5 from 6